InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by White Anne E., Vice-Président Senior. Director active across 1 company, notably ELI LILLY & Co. Aggregated, 8 reports have been recorded. History available since 1 February 2022. The latest transaction was disclosed on 10 February 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to White Anne E.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
6,828.871 shares@ US$868.8833.8% of flowCommon StockSEC:0000059478-25-000059:0
3,269 shares0Common StockSEC:0000059478-25-000032:0
5,363 shares@ US$737.2621.5% of flowCommon StockSEC:0000059478-24-000062:0
4,124 shares0Common StockSEC:0000059478-24-000013:0
8,562 shares@ US$345.1216.2% of flowCommon StockSEC:0000059478-23-000069:0
7,264 shares0Common StockSEC:0000059478-23-000043:0
11,348 shares@ US$243.270.0003% mcap50.0% of flowCommon StockSEC:0000059478-22-000056:0
9,368 shares0Common StockSEC:0000059478-22-000032:0
8 of 8 declarations
About White Anne E.
White Anne E. is a Senior Vice President and President of Lilly Neuroscience at ELI LILLY & Co. She is responsible for the strategic direction of the company's neuroscience initiatives. Her expertise in the pharmaceutical field is crucial for the development of new treatments and for innovation within the organization.
